AU2002349676A1 - 4-oxoquinoline derivatives - Google Patents
4-oxoquinoline derivativesInfo
- Publication number
- AU2002349676A1 AU2002349676A1 AU2002349676A AU2002349676A AU2002349676A1 AU 2002349676 A1 AU2002349676 A1 AU 2002349676A1 AU 2002349676 A AU2002349676 A AU 2002349676A AU 2002349676 A AU2002349676 A AU 2002349676A AU 2002349676 A1 AU2002349676 A1 AU 2002349676A1
- Authority
- AU
- Australia
- Prior art keywords
- oxoquinoline derivatives
- oxoquinoline
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- HETSDWRDICBRSQ-UHFFFAOYSA-N 3h-quinolin-4-one Chemical class C1=CC=C2C(=O)CC=NC2=C1 HETSDWRDICBRSQ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001-353064 | 2001-11-19 | ||
| JP2001353064 | 2001-11-19 | ||
| PCT/JP2002/012077 WO2003043992A1 (fr) | 2001-11-19 | 2002-11-19 | Derives de 4-oxyquinoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002349676A1 true AU2002349676A1 (en) | 2003-06-10 |
Family
ID=19165142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002349676A Abandoned AU2002349676A1 (en) | 2001-11-19 | 2002-11-19 | 4-oxoquinoline derivatives |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2002349676A1 (fr) |
| TW (1) | TW200300349A (fr) |
| WO (1) | WO2003043992A1 (fr) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
| DK1564210T5 (da) | 2002-11-20 | 2010-05-03 | Japan Tobacco Inc | 4-Oxoquinolinforbindelser og anvendelse deraf som HIV-integraseinhibitorer |
| SI2489659T1 (en) * | 2004-06-24 | 2018-04-30 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-binding cassette transporters |
| LT1993360T (lt) | 2005-12-28 | 2017-06-12 | Vertex Pharmaceuticals Incorporated | N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma |
| EA017861B9 (ru) | 2006-03-06 | 2014-05-30 | Джапан Тобакко Инк. | Способ получения 4-оксохинолинового соединения |
| US8420821B2 (en) | 2006-03-06 | 2013-04-16 | Japan Tobacco Inc. | Process for production of 4-oxoquinoline compound |
| SG10201501782UA (en) | 2006-09-12 | 2015-05-28 | Gilead Sciences Inc | Process and intermediates for preparing integrase inhibitors |
| AR068403A1 (es) | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | Proceso e intermediarios para la preparacion de inhibidores de integrasa |
| SG10201504084QA (en) | 2009-03-20 | 2015-06-29 | Vertex Pharma | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| PL3400944T3 (pl) | 2010-11-04 | 2020-11-16 | Albireo Ab | Inhibitory ibat w leczeniu chorób wątroby |
| AU2013226076B2 (en) | 2012-02-27 | 2017-11-16 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administration thereof |
| IN2015DN01688A (fr) | 2012-08-03 | 2015-07-03 | Gilead Sciences Inc | |
| WO2015199147A1 (fr) | 2014-06-25 | 2015-12-30 | 味の素株式会社 | Préparation pharmaceutique solide, et procédé d'inhibition ou d'atténuation de coloration de celle-ci |
| MX370450B (es) | 2014-10-07 | 2019-12-13 | Vertex Pharma | Co-cristales de moduladores de regulador de conductancia de transmembrana en fibrosis quistica. |
| CN108368087B (zh) | 2015-10-14 | 2022-04-12 | 百时美施贵宝公司 | 作为apj激动剂的2，4-二羟基-烟酰胺 |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| MY189454A (en) | 2016-03-24 | 2022-02-14 | Bristol Myers Squibb Co | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists |
| WO2019032026A1 (fr) | 2017-08-09 | 2019-02-14 | Albireo Ab | Granules de cholestyramine, formulations orales de cholestyramine et leur utilisation |
| US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| JP7391048B2 (ja) | 2018-06-05 | 2023-12-04 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| JOP20200299A1 (ar) | 2018-06-20 | 2020-11-22 | Albireo Ab | صيغة صيدلانية لأوديفيكسيبات |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| WO2020161217A1 (fr) | 2019-02-06 | 2020-08-13 | Albireo Ab | Composés de benzothiadiazépine et leur utilisation en tant que modulateurs d'acide biliaire |
| IL293379A (en) | 2019-12-04 | 2022-07-01 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| JP7665620B2 (ja) | 2019-12-04 | 2025-04-21 | アルビレオ・アクチボラグ | ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| JP7696898B2 (ja) | 2019-12-04 | 2025-06-23 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| CN114761080B (zh) | 2019-12-04 | 2024-07-23 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| CA3186857A1 (fr) | 2020-08-03 | 2022-02-10 | Per-Goran Gillberg | Composes de benzothia(di)azepine et leur utilisation en tant que modulateurs de l'acide biliaire |
| CA3196488A1 (fr) | 2020-11-12 | 2022-05-19 | Albireo Ab | Odevixibat pour le traitement de la cholestase intrahepatique familiale progressive (cifp) |
| AU2021390172A1 (en) | 2020-12-04 | 2023-06-22 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| TW202313579A (zh) | 2021-06-03 | 2023-04-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途 |
| JP2025519119A (ja) | 2022-05-25 | 2025-06-24 | イケナ オンコロジー， インコーポレイテッド | Ｍｅｋ阻害剤及びその使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10130241A (ja) * | 1996-10-31 | 1998-05-19 | Wakunaga Pharmaceut Co Ltd | 新規ピリドンカルボン酸誘導体又はその塩及びこれを含有する医薬 |
| AU1302301A (en) * | 1999-11-08 | 2001-06-06 | Sankyo Company Limited | Nitrogenous heterocycle derivatives |
-
2002
- 2002-11-18 TW TW091133622A patent/TW200300349A/zh unknown
- 2002-11-19 WO PCT/JP2002/012077 patent/WO2003043992A1/fr active Application Filing
- 2002-11-19 AU AU2002349676A patent/AU2002349676A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003043992A1 (fr) | 2003-05-30 |
| TW200300349A (en) | 2003-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002349676A1 (en) | 4-oxoquinoline derivatives | |
| AU2002313565A1 (en) | Putter-heads | |
| AU2002363600A1 (en) | Novel phenyl-propargylether derivatives | |
| AU2002319532A1 (en) | Feeding-bottles | |
| AU2002358715A1 (en) | Tetrahydrobenzfluorene derivatives | |
| AU2002313943A1 (en) | Electromobile | |
| AU2002226571A1 (en) | Biligands | |
| AU2001100406A4 (en) | DriverSMS | |
| AU2002313073A1 (en) | Phytocystatin | |
| AU2002255269B8 (en) | 2-Iminopyrrolidine derivatives | |
| AU2002325368A1 (en) | Benzoylcyclohexenone derivatives | |
| AU2002305184A1 (en) | Cycloalkenylsulfonamide derivatives | |
| AU2002354530A1 (en) | 4-phenylpyran-2-one derivatives | |
| AU2002255269A1 (en) | 2-Iminopyrrolidine derivatives | |
| AU2002253080A1 (en) | Biurethane derivatives | |
| AU2002249205A1 (en) | Bis-triazinylaminobenzoxazole derivatives | |
| HK1062431A (en) | A-amino-n-hydroxy-acetamide derivatives | |
| AU2002230196A1 (en) | Dicarba-closo-dodecarborane derivatives | |
| AU2002225034A1 (en) | Rustmicin derivatives | |
| AU2002302578A1 (en) | Amido-diphenyl derivatives | |
| AU2002350425A1 (en) | 6-phenyldihydropyrrolopyrimidinedione derivatives | |
| AU2002257925A1 (en) | Numberplates | |
| HK1082950A (en) | Novel arylheteroalkylamine derivatives | |
| AU2002328796A1 (en) | Novel aminoazetidine, -pyrrolidine and -piperidine derivatives | |
| AU2002313234A1 (en) | Novel endomorphine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |